Glycans as Biomarkers in Prostate Cancer

Prostate cancer is the most commonly diagnosed malignancy in men, claiming over 350,000 lives worldwide annually. Current diagnosis relies on prostate-specific antigen (PSA) testing, but this misses some aggressive tumours, and leads to the overtreatment of non-harmful disease. Hence, there is an ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Emma, Munkley, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470778/
https://www.ncbi.nlm.nih.gov/pubmed/30893936
http://dx.doi.org/10.3390/ijms20061389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470778/
https://www.ncbi.nlm.nih.gov/pubmed/30893936
http://dx.doi.org/10.3390/ijms20061389

Ejemplares similares